< Back to previous page
Researcher
Camila Esguerra
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Molecular Biodiscovery (Division)
Member
From1 Apr 2013 → 30 Nov 2014
Projects
1 - 5 of 5
- New treatment of cystinosis.From1 Mar 2015 → 28 Feb 2020Funding: FWO research project
- Establishment of zebrafish model of attention-deficit/hyperactivity disorderFrom1 Dec 2010 → 15 Jul 2016Funding: IWT personal funding - strategic basic research grants
- Functional analysis of novel, small-molecule modulators of BMP and Wnt signaling in zebrafish.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project
- A functional genomics study in zebrafish to elucidate the role of thyroid hormones and deiodinases in early embryonic development.From1 Jan 2010 → 31 Dec 2013Funding: FWO research project
- Functional Peptidomics Knowledge Platform.From1 Oct 2009 → 30 Sep 2013Funding: IOF - Industrial Research Fund
Publications
1 - 10 of 30
- Seizing the moment: Zebrafish epilepsy models(2020)
Authors: Camila Esguerra
Pages: 1 - 20 - New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome(2020)
Authors: Camila Esguerra
Pages: 549 - 560 - Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B(2019)
Authors: Daniëlle Copmans, Michèle Partoens, Camila Esguerra, Peter de Witte
- Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy(2019)
Authors: Camila Esguerra, Freddy Van Leuven, Peter de Witte
Pages: 1992 - 2003 - CHD2 variants are a risk factor for photosensitivity in epilepsy(2015)
Authors: Camila Esguerra
Pages: 1198 - 1207 - Deiodinase knockdown during early zebrafish development affects growth, development, energy metabolism, motility and phototransduction(2015)
Authors: Marjolein Heijlen, Anne Houbrechts, Camila Esguerra, Veerle Darras
Pages: 1 - 22 - Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish(2015)
Authors: Peter de Witte, Alexander Crawford, Camila Esguerra
Pages: 53 - 63 - Pharmacological characterization of an antisense knockdown zebrafish model of dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine(2015)
Authors: Yifan Zhang, Daniëlle Copmans, Lieven Lagae, Peter de Witte, Camila Esguerra
- Smoc2 Modulates Embryonic Myelopoiesis During Zebrafish Development(2014)
Authors: Hendrik Mommaerts, Camila Esguerra, Frank Luyten, Przemyslaw Tylzanowski
Pages: 1375 - 1390 - The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson disease(2014)
Authors: Pieter Spincemaille, Duc Hung Pham, Jef Verbeek, Louis Libbrecht, Camila Esguerra, Peter de Witte, Bruno Cammue, David Cassiman, Karin Thevissen
Pages: 345 - 351
Patents
1 - 8 of 8
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Anticonvulsant activity of bisabolene sesquiterpenoids isolated from turmeric oil (Inventor)
- Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids (Inventor)
- DAN SHEN EXTRACTS AND COMPOUNDS (Inventor)
- ANTICONVULSANT ACTIVITY OF GSK-3BETA INHIBITORS (Inventor)